Royal Philips and B. Braun received FDA approval to sell the latest version of the ultrasound system Onvision. The novelty uses a special needle Stimuplex Onvision. It allows anesthesiologists to track the exact position of the needle in the patient's body in real time, which provides a point injection of anesthesia to block the peripheral nerves. The system is already available throughout the EU and Chile, and sales in the U.S. are scheduled to begin in Q4 2020.